Access for Life

Access For Life

Medical Devices, 625 Gramatan Ave, Fleetwood, New York, 10552, United States, 1-10 Employees

accessforlife.biz

  • facebook
  • LinkedIn

phone no Phone Number: +17*********

Who is ACCESS FOR LIFE

The Challenge: Vascular access in chronic care patients, e.g. hemodialysis, results in clinical complications with significant patient morbidity, mortality and greater healthcare costs. D...

Read More

map
  • 625 Gramatan Ave, Fleetwood, New York, 10552, United States Headquarters: 625 Gramatan Ave, Fleetwood, New York, 10552, United States
  • 2015 Date Founded: 2015
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 8062

checked-icon Does something look wrong? Fix it. | View contact records from ACCESS FOR LIFE

Access for Life Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Access for Life

Answer: Access for Life's headquarters are located at 625 Gramatan Ave, Fleetwood, New York, 10552, United States

Answer: Access for Life's phone number is +17*********

Answer: Access for Life's official website is https://accessforlife.biz

Answer: Access for Life's revenue is Under $1 Million

Answer: Access for Life's SIC: 8062

Answer: Access for Life has 1-10 employees

Answer: Access for Life is in Medical Devices

Answer: Access for Life contact info: Phone number: +17********* Website: https://accessforlife.biz

Answer: The Challenge: Vascular access in chronic care patients, e.g. hemodialysis, results in clinical complications with significant patient morbidity, mortality and greater healthcare costs. Dialysis patients undergo treatments at least three times/week, 4 hours a session, requiring nurses/technicians to blindly stick needles (cannulation) into high flow veins, i.e. Arteriovenous (AV) fistulas/grafts. There have been no significant innovations in vascular access for over 50 years. The Solution: The JEMTM unique, patented Smart device will become the Gold Standard for safe venous access and preservation of the AV fistula or graft and real-time data gathering. It is expected to greatly reduce the costs of repair and replacement of AV fistulas. The JEMTM is an easy-to-use, safe Smart device that acts as a needle guide to safely direct a needle into the vein, avoiding vessel damage and reducing patient pain. The JEMTM allows less skilled caregivers to assist patients, or the patients themselves, to cannulate safely and simply. It encourages home and self-care hemodialysis and can use a blunt needle, which results in less pain to the patient. The JEMTM transmits monitoring data on the patients vascular system to warn of serious changes that could compromise fistula function. The embedded sensors also gather real-time data on the dialysis process, e.g. patient blood flow and diagnostic information to help predict and prevent major dialysis risks. E.g. indicating possible locations of stenosis and avoiding occlusion. This is digital health at its best. The JEM represents a completely disruptive and innovative breakthrough in the field of repetitive vascular access. It will become the Gold Standard for safe venous access, preservation of the AV fistula or graft and real-time data gathering. It is expected to greatly reduce the costs of repair and replacement of AV fistulas, thereby saving healthcare system costs.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access